PRE-FUNDED COMMON STOCK PURCHASE WARRANT applied dna sciences, inc.Applied Dna Sciences Inc • February 23rd, 2022 • Services-miscellaneous business services
THIS PRE-FUNDEDCOMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) until this Warrant is exercised in full] (the “Termination Date”) but not thereafter, to subscribe for and purchase from Applied DNA Sciences, Inc., a Delaware corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • February 23rd, 2022 • Applied Dna Sciences Inc • Services-miscellaneous business services • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of February 21, 2022, between Applied DNA Sciences, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • November 3rd, 2016 • Applied Dna Sciences Inc • Services-miscellaneous business services
This Agreement is made pursuant to the Securities Purchase Agreement, dated as of the date hereof, between the Company and each Purchaser (the “Purchase Agreement”).
WARRANT AGREEMENT APPLIED DNA SCIENCES, INC. and AMERICAN STOCK TRANSFER & TRUST COMPANY WARRANT AGREEMENT Dated as of November ___, 2014Warrant Agreement • October 30th, 2014 • Applied Dna Sciences Inc • Services-miscellaneous business services • New York
THIS WARRANT AGREEMENT (this “Agreement”), dated as of November ___, 2014, is by and between Applied DNA Sciences, Inc., a Delaware corporation (the “Company”), and American Stock Transfer & Trust Company, LLC, a New York limited liability trust company, as warrant agent (the “Warrant Agent”, also referred to herein as the “Transfer Agent”).
EXHIBIT 10.1 APPLIED DNA SCIENCES, INC. Applied DNA Sciences, Inc., a Nevada corporation (the "Company"), hereby certifies that, for value received, _________________________ (the "Warrant Holder," which term includes its successors and registered...Applied Dna Sciences Inc • September 7th, 2006 • Biological products, (no disgnostic substances) • New York
APPLIED DNA SCIENCES, INC. WARRANT AGREEMENT, dated March __, 2006 (the "Agreement"), by and between Applied DNA Sciences, Inc., a Nevada corporation (the "Company"), and __________________ (individually the "Warrant Holder" and collectively with...Warrant Agreement • March 14th, 2006 • Applied Dna Sciences Inc • Biological products, (no disgnostic substances) • New York
EXHIBIT 10.3 APPLIED DNA SCIENCES, INC. Applied DNA Sciences, Inc., a Nevada corporation (the "Company"), hereby certifies that, for value received, _________________________ (the "Warrant Holder," which term includes its successors and registered...Applied Dna Sciences Inc • May 5th, 2006 • Biological products, (no disgnostic substances) • New York
RECITALSStock Purchase Agreement • February 2nd, 2005 • Applied Dna Sciences Inc • Services-computer processing & data preparation • Nevada
EXHIBIT 10.1 SUBSCRIPTION AGREEMENT Applied DNA Sciences, Inc. 25 Health Sciences Drive, Suite 113 Stony Brook, New York 11790 Gentlemen and Ladies: The undersigned (the "Subscriber") hereby subscribes for ________ units, at a price of $50,000 per...Subscription Agreement • May 5th, 2006 • Applied Dna Sciences Inc • Biological products, (no disgnostic substances) • New York
Exhibit 10.12 INVESTMENT ADVISORY AGREEMENT This Investment Advisory Agreement made this 14th day of February 2005 is between Applied DNA Sciences, Inc., a Nevada corporation located at 9229 West Sunset Blvd., Suite 830, Los Angeles, CA 9009...Investment Advisory Agreement • February 15th, 2005 • Applied Dna Sciences Inc • Biological products, (no disgnostic substances)
Exhibit 10.3 CONSULTING AGREEMENT This Consulting Agreement ("Agreement") is being entered into as of this 12th day of July, 2005, between APPLIED DNA SCIENCES, INC., a Nevada corporation (the "Company"), with offices at 9229 West Sunset Bvd, Suite...Consulting Agreement • July 21st, 2005 • Applied Dna Sciences Inc • Biological products, (no disgnostic substances) • California
EXHIBIT 10.4 REGISTRATION RIGHTS AGREEMENT This REGISTRATION RIGHTS AGREEMENT (this "Agreement"), is made as of May ___, 2006, by and among Applied DNA Sciences, Inc., a Nevada corporation (the "Company"), and each of the undersigned (individually,...Registration Rights Agreement • May 5th, 2006 • Applied Dna Sciences Inc • Biological products, (no disgnostic substances) • New York
FORM OF COMMON STOCK PURCHASE WARRANT APPLIED DNA SCIENCES, INC.Applied Dna Sciences Inc • February 1st, 2024 • Services-testing laboratories • New York
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the Approval Effective Date (as defined in the Purchase Agreement) (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on the fifth anniversary of the Approval Effective Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from Applied DNA Sciences, Inc., a Delaware corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of the Company’s Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). For purposes hereof, “Shareholder Approval” means such approval, if required, by the applicable rules and regulations of the Nasdaq Stock
Engagement AgreementLetter Agreement • February 15th, 2005 • Applied Dna Sciences Inc • Biological products, (no disgnostic substances) • New York
SHARE EXCHANGE AGREEMENT THIS AGREEMENT is made this 4th day of May, 1999 by and among DCC Acquisition Corp., a Nevada corporation, hereinafter called "DCC", New Cinema Partners Inc., an Ontario, Canada corporation, hereinafter called "NCPI:, and The...Share Exchange Agreement • June 11th, 1999 • DCC Acquisition Corp • Services-computer processing & data preparation • Nevada
RECITALSIndemnity Agreement • February 15th, 2005 • Applied Dna Sciences Inc • Biological products, (no disgnostic substances) • Delaware
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • February 1st, 2024 • Applied Dna Sciences Inc • Services-testing laboratories • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of January 31, 2024, between Applied DNA Sciences, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • January 11th, 2021 • Applied Dna Sciences Inc • Services-miscellaneous business services • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of January 10, 2021, between Applied DNA Sciences, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
BETWEENDevelopment Agreement • October 28th, 2005 • Applied Dna Sciences Inc • Biological products, (no disgnostic substances)
FORM OF PRE-FUNDED COMMON STOCK PURCHASE WARRANT APPLIED DNA SCIENCES, INC.Applied Dna Sciences Inc • February 1st, 2024 • Services-testing laboratories
THIS PRE-FUNDED COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) until this Warrant is exercised in full (the “Termination Date”) but not thereafter, to subscribe for and purchase from Applied DNA Sciences, Inc., a Delaware corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • July 22nd, 2013 • Applied Dna Sciences Inc • Industrial organic chemicals • New York
This REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of July 19, 2013, is by and among Applied DNA Sciences, Inc., a Delaware corporation (the “Company”), and the undersigned buyer (the “Buyer”).
Exhibit 2.1 PLAN AND AGREEMENT OF REORGANIZATION UNDER I.R.C. 368(a) (1) (B) PROHEALTH MEDICAL TECHNOLOGIES, INC. AND RHL MANAGEMENT CORPORATION AND LAWRENCE LEE collectively, THE SHAREHOLDERS OF APPLIED DNA SCIENCES, INC. THIS PLAN AND AGREEMENT OF...Plan and Agreement • October 28th, 2002 • Prohealth Medical Technologies Inc • Services-computer processing & data preparation • Texas
PLACEMENT AGENCY AGREEMENT January 31, 2024Placement Agency Agreement • February 1st, 2024 • Applied Dna Sciences Inc • Services-testing laboratories • New York
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • November 23rd, 2015 • Applied Dna Sciences Inc • Services-miscellaneous business services • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of November 23, 2015 between Applied DNA Sciences, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
Exhibit 10.1 AGREEMENT OF LEASE LONG ISLAND HIGH TECHNOLOGY INCUBATOR, INC. Applied DNA November 2005 thru October 2006 AGREEMENT OF LEASE This Lease dated this First day November 2005 is by and between LONG ISLAND HIGH TECHNOLOGY INCUBATOR, INC., a...Agreement of Lease • October 27th, 2005 • Applied Dna Sciences Inc • Biological products, (no disgnostic substances)
PRE-FUNDED COMMON STOCK PURCHASE WARRANT APPLIED DNA SCIENCES, INC.Applied Dna Sciences Inc • October 25th, 2019 • Services-miscellaneous business services • New York
THIS PRE-FUNDED COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and until this Warrant is exercised in full (the “Termination Date”) but not thereafter, to subscribe for and purchase from Applied DNA Sciences, Inc., a Delaware corporation (the “Company”), up to ______ shares of Common Stock, par value $0.001 per share (the “Common Stock”) (as subject to adjustment hereunder, the “Warrant Shares”). The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant is one of the Warrants issued pursuant to the Company’s Registration Statement on Form S-1 (File number 333-233830) (the “Registration Statement”).
COMMON STOCK PURCHASE WARRANT APPLIED DNA SCIENCES, INC.Applied Dna Sciences Inc • December 21st, 2018 • Services-miscellaneous business services • New York
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to the close of business on the five year anniversary of the Initial Exercise Date (the “Termination Date”; provided, however that if such date is not a Trading Day, the Termination Date shall be the immediately following Trading Day) but not thereafter, to subscribe for and purchase from Applied DNA Sciences, Inc., a Delaware corporation (the “Company”), up to _____ shares of Common Stock, par value $0.001 per share (the “Common Stock”) (as subject to adjustment hereunder, the “Warrant Shares”). The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 1(b). This Warrant is one of the Warrants
Exhibit 4.5 SECURITY AGREEMENT SECURITY AGREEMENT dated January 28, 2005, between Vertical Capital Partners, Inc., a Delaware corporation, as agent (the "Agent") for the benefit of the individuals or entities listed on Schedule A hereto ("Creditor"),...Security Agreement • January 28th, 2005 • Applied Dna Sciences Inc • Services-computer processing & data preparation • New York
PLACEMENT AGENT COMMON STOCK PURCHASE WARRANT APPLIED DNA SCIENCES, INC.Applied Dna Sciences Inc • May 15th, 2024 • Services-testing laboratories • New York
PLACEMENT AGENT COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, [___________] or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on [_____], 20291 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Applied DNA Sciences, Inc., a Delaware corporation (the “Company”), up to [______] shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant is being issued pursuant to the certain Placement Agency Agreement, dated as of [_____], 2024, by and between the Company, Craig-Hallum Capital Group LLC and Laidlaw Company (UK) Ltd.
Exhibit 10.2 INDEPENDENT CONTRACTOR AGREEMENT THIS INDEPENDENT CONTRACTOR AGREEMENT ("Agreement") is entered into by and between APPLIED DNA SCIENCES, INC. a Nevada corporation with its offices located at 9229 Sunset Blvd., Suite 830, West Hollywood,...Independent Contractor Agreement • October 27th, 2005 • Applied Dna Sciences Inc • Biological products, (no disgnostic substances) • California
APPLIED DNA SCIENCES, INC. Up to $6,397,939 of Common Stock EQUITY DISTRIBUTION AGREEMENTEquity Distribution Agreement • November 7th, 2023 • Applied Dna Sciences Inc • Services-testing laboratories • New York
Applied DNA Sciences, Inc., a Delaware corporation (the “Company”), proposes to issue and sell through Maxim Group LLC, as exclusive sales agent (the “Agent”), shares of common stock, par value $0.001 per share, of the Company (the “Common Stock”), having an aggregate offering price of up to $6,397,939 (the Common Stock subject to this Equity Distribution Agreement (this “Agreement”) being referred to herein as the “Shares”) on terms set forth herein and subject to the limitations set forth in Section 2 hereof. The Shares consist entirely of authorized but unissued shares of Common Stock to be issued and sold by the Company.
Exhibit 4.4 REGISTRATION RIGHTS AGREEMENT THIS REGISTRATION RIGHTS AGREEMENT (this "Agreement"), is made as of January 28, 2005, by and among APPLIED DNA SCIENCES, INC. (the "Company") and VERTICAL CAPITAL PARTNERS, INC. (the "Investor...Registration Rights Agreement • January 28th, 2005 • Applied Dna Sciences Inc • Services-computer processing & data preparation • New York
SERIES D COMMON STOCK PURCHASE WARRANT APPLIED DNA SCIENCES, INC.Applied Dna Sciences Inc • October 31st, 2024 • Services-testing laboratories • New York
THIS SERIES D COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, [___________] or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the Stockholder Approval Date (as defined below) (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on the eighteen (18) month anniversary of the Initial Exercise Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from Applied DNA Sciences, Inc., a Delaware corporation (the “Company”), up to [______] shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
COMMON STOCK PURCHASE WARRANT APPLIED DNA SCIENCES, INC.Applied Dna Sciences Inc • October 14th, 2020 • Services-miscellaneous business services
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, ___________________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to the close of business on the five (5) year anniversary of the Initial Exercise Date (the “Termination Date”; provided, however that if such date is not a Trading Day, the Termination Date shall be the immediately following Trading Day) but not thereafter, to subscribe for and purchase from Applied DNA Sciences, Inc., a Delaware corporation (the “Company”), up to ______ shares of Common Stock, par value $0.001 per share (the “Common Stock”) (as subject to adjustment hereunder, the “Warrant Shares”). The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant is one of t
2,800,000 Shares of Common Stock and 2,800,000 Warrants to Purchase Shares of Common Stock APPLIED DNA SCIENCES, INC. UNDERWRITING AGREEMENTUnderwriting Agreement • December 15th, 2014 • Applied Dna Sciences Inc • Services-miscellaneous business services • New York
Applied DNA Sciences, Inc., a Delaware corporation (the “Company”), proposes, subject to the terms and conditions contained herein, (this “Agreement”), to sell to you and the other underwriters named on Schedule I to this Agreement (the “Underwriters”), for whom Maxim Group LLC (“Maxim”) is acting as Representative (the “Representative,” “you” or similar terminology), an aggregate of 2,800,000 shares of the Company’s common stock, $0.001 par value per share (the “Common Stock”), and 2,800,000 warrants (the “Warrants”) with the right to purchase one share of Common Stock (together, “Securities”). The respective numbers of Securities to be purchased by each of the several Underwriters are set forth opposite their names on Schedule I hereto. In addition, the Company proposes to grant to the Underwriters an option to purchase up to an additional 420,000 shares of Common Stock (the “Option Shares”) and/or up to an additional 420,000 Warrants (the “Option Warrants”) from the Company for the
